Skip to main content

Articles

Page 3 of 38

  1. Recently, silver nanoparticles (Ag-NPs) were shown to provoke oxidative stress through the release of reactive oxygen species and consequently induce cell damage. Selenium-loaded chitosan nanoparticles (CS-SeN...

    Authors: Omnia E. Shalaby, Yasmine H. Ahmed, Aya M. Mekkawy, Mohamed Y. Mahmoud and G. A. Elbargeesy
    Citation: Journal of Ovarian Research 2025 18:4
  2. A significant overlap in the pathophysiological features of polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus (T2DM) has been reported; and insulin resistance is considered a central driver in both...

    Authors: Idrees A. Shah, Rabiya Rashid, Haroon Rashid, Abid Bhat and Mohd Ashraf Ganie
    Citation: Journal of Ovarian Research 2025 18:2
  3. Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. It is characterized by symptoms such as hyperandrogenemia, oligo or anovulation and polycystic ovarian, sign...

    Authors: Wenxiu Chen, Jianliang Miao, Jingfei Chen and Jianlin Chen
    Citation: Journal of Ovarian Research 2025 18:1
  4. He Shi Yu Lin Formula (HSYLF) is a clinically proven prescription for treating premature ovarian insufficiency (POI), and has shown a good curative effect. However, its molecular mechanisms are unclear. This s...

    Authors: Yun Huang, Qin Zhang, Dan Shen and Xi Bao
    Citation: Journal of Ovarian Research 2024 17:254
  5. Previous work indicated that the implantation and pregnancy rates of women with endometriosis are lower than those of healthy women during in-vitro fertilisation and embryonic transfer. And there are numerous ...

    Authors: Xiong Li, Jing Fu, Wanjun Jiang, Wenbi Zhang, Yan Xu, Ruihuan Gu, Ronggui Qu, Yaoyu Zou, Zhichao Li, Yijuan Sun and Xiaoxi Sun
    Citation: Journal of Ovarian Research 2024 17:253
  6. Immune checkpoint-based immunotherapy has shown limited efficacy in the treatment of ovarian cancer. In recent years, the emergence of immune checkpoint co-targeting therapies, led by the combination targeting...

    Authors: Fengzhen Chen, Yanying Xu, Xiangyu Liu, Na Dong and Lei Tian
    Citation: Journal of Ovarian Research 2024 17:252
  7. Cyclophosphamide is a widely utilized chemotherapeutic agent for pediatric cancers, known to elicit adverse effects, including perturbation of the PI3K/Akt/mTOR and Hippo signaling pathways, thereby diminishin...

    Authors: Negin Zatalian, Azam Dalman, Parvaneh Afsharian, Maryam Hezavehei and Hamid Gourabi
    Citation: Journal of Ovarian Research 2024 17:251
  8. To investigate the changes in bile acid (BA) metabolites within the follicular fluid (FF) of patients with diminished ovarian reserve (DOR) and to identify novel diagnostic markers that could facilitate early ...

    Authors: Shu Ding, Wenyan Li, Xianglei Xiong, Manfei Si, Chuyu Yun, Yuqian Wang, Lixuan Huang, Sen Yan, Xiumei Zhen, Jie Qiao and Xinyu Qi
    Citation: Journal of Ovarian Research 2024 17:250
  9. To compare the efficacy and safety of metformin, anti-obesity agents, and inositol with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).

    Authors: Lijun Lin, Ge Chen, Xiaoyong Qiao, Yan Chen, Hongxia Deng and Liangzhi Xu
    Citation: Journal of Ovarian Research 2024 17:249
  10. Polycystic ovary syndrome (PCOS) is among the most prevalent endocrine and metabolic disorders affecting women of reproductive age. Multiple factors, including genetic predisposition, environmental influences,...

    Authors: Li Qin, Chun Tian, Liying Huang, Xiao Qin, Shaohua Ling, Jingxi Wei, Bingsheng Huang, Lining Li and Xiaoqiong Luo
    Citation: Journal of Ovarian Research 2024 17:248
  11. Polycystic ovary syndrome (PCOS) is a common complication of autoimmune thyroiditis (AIT) in women, but the underlying mechanism remains unclear. Protein disulfide isomerase A3 (PDIA3) is a ubiquitous protein....

    Authors: Zhaoying Chen, Chenxi Zhang, Chunfeng Meng, Yadan Hu, Yazhuo Niu, Bingrui Gao, Jinshuo Wang, Lu Liu, Kan Chen, Zhongyan Shan, Weiping Teng and Jing Li
    Citation: Journal of Ovarian Research 2024 17:247
  12. Cisplatin (DDP) is one of the most effective anticancer drugs, commonly used to treat advanced ovarian cancer (OC). However, DDP has significant limitations of platinum-based drugs, including chemical resistan...

    Authors: Xue Sui, Bingqing Gao, Liu Zhang, Yanmin Wang, Junnan Ma, Xingchen Wu, Chenyu Zhou, Min Liu and Lin Zhang
    Citation: Journal of Ovarian Research 2024 17:246
  13. As a widespread epidemic, obesity poses a significant risk to health and leads to physiological abnormalities, including diabetes mellitus and inflammation. Obesity-induced inflammation can accelerate the deve...

    Authors: Zhe Wang, Qingjian Ou, Ying Liu, Yuanyuan Liu, Qingwei Zhu, Jingqiu Feng, Fengze Han and Lu Gao
    Citation: Journal of Ovarian Research 2024 17:245
  14. Polycystic ovary syndrome (PCOS) is the most common endocrine disorder occurring in women of reproductive age. The disease is caused by a complex interplay of genetic and environmental factors including genes ...

    Authors: Rongling Wu and Claudia Gragnoli
    Citation: Journal of Ovarian Research 2024 17:242
  15. The female reproductive system dysfunction considerably affects the overall health of women and children on a global scale. Over the decade, the incidence of reproductive disorders has become a significant sou...

    Authors: Maya Lakshmanan, Monika Saini and Manasa Nune
    Citation: Journal of Ovarian Research 2024 17:241
  16. High-grade serous ovarian cancer (HGSOC) is marked by significant molecular diversity, presenting a major clinical challenge due to its aggressive nature and poor prognosis. This study aims to deepen the under...

    Authors: Kaylin M. Carey, Corey D. Young, Alexis J. Clark, Eric B. Dammer, Rajesh Singh and James W. Lillard Jr.
    Citation: Journal of Ovarian Research 2024 17:240
  17. Authors: Amany I. Ahmed, Mohamed F. Dowidar, Asmaa F. Negm, Hussein Abdellatif, Asma Alanazi, Mohammed Alassiri, Walaa Samy, Dina Mohamed Mekawy, Eman M. A. Abdelghany, Nesma I. El-Naseery, Mohamed A. Ibrahem, Emad Ali Albadawi, Wed Salah, Mamdouh Eldesoqui, Emil Tîrziu, Iulia Maria Bucur…
    Citation: Journal of Ovarian Research 2024 17:239

    The original article was published in Journal of Ovarian Research 2024 17:184

  18. Follicular fluid (FF) plays a vital role in the bidirectional communication between oocytes and granulosa cells (GCs), regulating and promoting oocyte growth and development. This fluid constitutes a complex m...

    Authors: Yurong Pan, Chenyu Pan and Chunping Zhang
    Citation: Journal of Ovarian Research 2024 17:237
  19. Premature ovarian insufficiency (POI) is a common clinical problem, but there is currently no effective treatment. NLRP3 inflammasome-induced pyroptosis is thought to be a possible mechanism of POI. Nicotinami...

    Authors: Yue Ma, Weihua Nong, Ou Zhong, Ke Liu, Siyuan Lei, Chen Wang, Xi Chen and Xiaocan Lei
    Citation: Journal of Ovarian Research 2024 17:236
  20. Pentraxin 3 (PTX3) has been associated with the development and progression of various malignant tumors. However, its roles and the mechanisms underlying its involvement in ovarian cancer (OC) peritoneal metas...

    Authors: Shuangyan Liu, Tianhao Wu, Xueying Song, Linru Quan, Xinyi Wang, Qing Liu and Xin Zhou
    Citation: Journal of Ovarian Research 2024 17:235
  21. To analyze how the PD-L1 expression and CD8 + tumor infiltrating lymphocyte (TIL) levels in biopsy samples before neoadjuvant chemotherapy (NACT) can predict chemotherapy response score and survival for advanc...

    Authors: T. Aliyeva, B. Y. Aktas, F. Gundogdu, E. Chalabiyev, Z. Arik and A. Usubutun
    Citation: Journal of Ovarian Research 2024 17:234
  22. Disturbances in the gut microbiota may act as mechanisms influencing the interplay between dietary factors and metabolic disorders. Studies have demonstrated that these alterations are associated with the diag...

    Authors: Thaís Rasia da Silva, Lucas Bandeira Marchesan, Pabulo Henrique Rampelotto, Larisse Longo, Tiago Franco de Oliveira, Rikard Landberg, Vanessa de Mello and Poli Mara Spritzer
    Citation: Journal of Ovarian Research 2024 17:232
  23. The Coronavirus disease 2019 (COVID-19) pandemic has emerged as a global health crisis, with clinical manifestations including those suggesting injury to various organs such as the ovaries, which implies that ...

    Authors: Tianjin Yang, Guanjian Li, Huayan Yin, Longmei Wu, Yunxia Cao and Bing Song
    Citation: Journal of Ovarian Research 2024 17:231
  24. Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder accompanied by ovulatory dysfunction. Insulin resistance (IR) is a key pathogenic mechanism in PCOS, and insulin sensitizers, such as met...

    Authors: Fuzhen Zhao, Wei Cui, Chengmei Fang, Yuanyuan Luo and Cheng Zhang
    Citation: Journal of Ovarian Research 2024 17:229
  25. Polycystic ovary syndrome (PCOS), a hormonal disorder affecting women of reproductive age, can be significantly impacted by diet. This study explores the relationship between a diet rich in phytochemicals, mea...

    Authors: Yasong Chi, Ruiqin Yue, Yanru Lv, Haiyan Li and Wei Liao
    Citation: Journal of Ovarian Research 2024 17:228
  26. There is evidence indicating that chemoresistance in tumor cells is mediated by the reconfiguration of the tricarboxylic acid cycle, leading to heightened mitochondrial activity and oxidative phosphorylation (...

    Authors: Mary P. Udumula, Faraz Rashid, Harshit Singh, Tim Pardee, Sanjeev Luther, Tanya Bhardwaj, Km Anjaly, Sofia Piloni, Miriana Hijaz, Radhika Gogoi, Philip A. Philip, Adnan R. Munkarah, Shailendra Giri and Ramandeep Rattan
    Citation: Journal of Ovarian Research 2024 17:226
  27. Near-infrared fluorescence (NIRF) imaging is an excellent choice for image-guided surgery due to its simple operation and non-invasiveness. Developing tumor-specific fluorescent molecular probes is key to fluo...

    Authors: Chen Zhang, Hongyan Cheng, Sha Dou, Yuanfen Wang, Xue Ye, Heng Cui, Xiaohong Chang and Yi Li
    Citation: Journal of Ovarian Research 2024 17:225
  28. Premature ovarian insufficiency (POI) is a disease with medical, psychological and reproductive implications, but its common therapies have limited efficacy and a likelihood of complications. This study delves...

    Authors: Hui Miao, Congxiu Miao, Na Li and Jing Han
    Citation: Journal of Ovarian Research 2024 17:224
  29. Polycystic ovary syndrome (PCOS) is highly prevalent in women of reproductive age worldwide, exhibits highly heterogeneous clinical presentation and biochemical parameters, and has no cure. This study aimed to...

    Authors: Xueying Cui, Xiaocan Lei, Tao Huang, Xueyan Mao, Zhiwei Shen, Xiuli Yang, Wanting Peng, Jingjing Yu, Shun Zhang and Peng Huo
    Citation: Journal of Ovarian Research 2024 17:223

    The Correction to this article has been published in Journal of Ovarian Research 2025 18:82

  30. Chemotherapy detrimentally impacts fertility via depletion of follicular reserves in the ovaries leading to ovarian failure (OF) and development of estrogen deficiency-related complications. The currently prop...

    Authors: Nehal M. Elsherbiny, Mohamed S. Abdel-Maksoud, Kousalya Prabahar, Zuhair M. Mohammedsaleh, Omnia A. M. Badr, Arigue A. Dessouky, Hoda A. Salem, Omnia A. Refadah, Ayman Samir Farid, Ashraf A. Shamaa and Nesrine Ebrahim
    Citation: Journal of Ovarian Research 2024 17:222
  31. Recent studies have revealed that the Sry-related HMG box gene 17 (SOX17) plays an important role in ovarian carcinogenesis. Unlike other types of ovarian cancer, ovarian clear cell carcinoma (OCCC) has a distinc...

    Authors: Daichi Kodama, Motoki Takenaka, Chiemi Saigo, Masako Azuma, Yuki Hanamatsu, Masanori Isobe and Tamotsu Takeuchi
    Citation: Journal of Ovarian Research 2024 17:221
  32. Infertility is a reproductive health problem that attracts worldwide attention. Polycystic ovary syndrome (PCOS) is a major cause of female infertility and patients with obesity and PCOS are particularly commo...

    Authors: Xin Xin, Li Dong, Jiaxi Li, Wen Chen, Yue Qiu, Fang Lian and Haicui Wu
    Citation: Journal of Ovarian Research 2024 17:220
  33. Transcript variants and protein isoforms are central to unique tissue functions and maintenance of homeostasis, in addition to being associated with aberrant states such as cancer, where their crosstalk with t...

    Authors: Aravindan Narayanan, Ankita S. More, Muskan Talreja, Avinash M. Mali, Sannannagari Boya Vinay and Sharmila A. Bapat
    Citation: Journal of Ovarian Research 2024 17:218
  34. Polycystic ovary syndrome (PCOS) is defined as a chronic low-grade inflammatory reproductive endocrine disorder. PCOS can induce various metabolic disorders, which are associated with a state of mild and slow-...

    Authors: Danling Tian, Jinfeng Chen and Liang Liu
    Citation: Journal of Ovarian Research 2024 17:217
  35. Premature Progesterone Rise (PPR) is characterized by elevated serum progesterone concentrations either towards the end of the follicular phase or on the trigger day, surpassing a pre-defined threshold value. ...

    Authors: D. Baldini, V. M. Bartoli, A. Mastrorocco, D. Ferri, M. Dellino, A. S. Laganà, S. Hatirnaz, G. M. Baldini, A. Malvasi, A. Vimercati and G. Trojano
    Citation: Journal of Ovarian Research 2024 17:216
  36. Particulate matter 2.5 (PM2.5) pollution has emerged as a major global public health concern because of its adverse effects on human health. Our group has previously demonstrated that PM2.5 exposure can seriou...

    Authors: Xiandan Zhang, Xuan Wang, Hao Li, Haihong Wang, Dewei Du and Huijuan Huang
    Citation: Journal of Ovarian Research 2024 17:215
  37. Polycystic ovary syndrome (PCOS) is a complex heterogenous disorder manifesting with various reproductive, endocrine, and metabolic derangements such as insulin resistance and hyperglycemia. The arginine vasop...

    Authors: Pruthvi Goparaju and Claudia Gragnoli
    Citation: Journal of Ovarian Research 2024 17:214
  38. Poor ovarian response (POR) to controlled ovarian stimulation (COS) remains challenging, especially in advanced-age women with diminished ovarian reserve, resulting in low live birth rates. Many patients prefe...

    Authors: Anahid Shafie, Ashraf Aleyasin, Mojtaba Saffari, Mojtaba Saedi, Sahar Rostami, Saeede Rezayi, Seyed Danial Mohammadi and Fardin Amidi
    Citation: Journal of Ovarian Research 2024 17:212
  39. Lifestyle intervention is the first-line treatment for PCOS. Numerous studies have investigated the effect of various lifestyle factors, including dietary habit, smoking, and alcohol consumption on PCOS women....

    Authors: Yang Yang, Hua Zhang, Bo-Yun Huang, Yong-Hao Lu, Ii Fukuzawa, Shuhan Yang, Lifei Zhou, Liyan Luo, Chunyong Wang, Ning Ding, Sai Li, Li Shi and Hao-Lin Zhang
    Citation: Journal of Ovarian Research 2024 17:211
  40. Cancer antigen 125 (CA125) is widely used for screening ovarian cancer (OC), yet its effectiveness remains debated. Potential factors may include ineffective cut-off value for CA125 in screening, as well as a ...

    Authors: Hongyuan Duan, Xiaomin Liu, Yu Zhang, Ya Liu, Yuting Ji, Yunmeng Zhang, Zeyu Fan, Siwen Liu, Lei Yang, Tingting Xu, Jing Tian, Weiqin Li, Zhangyan Lyu, Fangfang Song, Fengju Song and Yubei Huang
    Citation: Journal of Ovarian Research 2024 17:210
  41. Anti-Müllerian hormone (AMH) is a widely used marker for estimating ovarian reserve, and it may predict response to ovarian stimulation. While AMH is considered a stable, cycle-independent marker, studies have...

    Authors: Yavuz Emre Şükür, Batuhan Aslan, Necati Berk Kaplan, Musa Doğru, Batuhan Özmen, Murat Sönmezer, Bülent Berker, Cem Somer Atabekoğlu and Ruşen Aytaç
    Citation: Journal of Ovarian Research 2024 17:209
  42. Immunotherapy has revolutionized the treatment of ovarian cancer (OC), but different immune microenvironments often constrain the efficacy of immunotherapeutic interventions. Therefore, there is an imperative ...

    Authors: Wen Gao, Hui Yuan, Sheng Yin, Renfang Deng and Zhaodong Ji
    Citation: Journal of Ovarian Research 2024 17:208

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.8
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 0.957
    SCImago Journal Rank (SJR): 0.968

    Speed 2024
    Submission to first editorial decision (median days): 8
    Submission to acceptance (median days): 124

    Usage 2024
    Downloads: 1,443,643
    Altmetric mentions: 320

News

New Content ItemEditor-in-Chief Dr Ben Tsang has been selected as a 2025 Distinguished Fellow by the Society for the Study of Reproduction (SSR) Awards Committee. Please join us in celebrating this amazing achievement. 

A new FDA approved phase I/II clinical trial on recurrent ovarian cancer is now open for enrollment.

Currently recruiting patients at the Brown Cancer Center, University of Louisville, Louisville, KY. UofL. IRB# 22.0392. NCT# 05610735. Please contact: Dr. Whitney Goldsberry or Dr. Sham S. Kakar.

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.